
Peter DeYoung, CEO, Piramal Pharma Solutions, talks about recent company achievements and key offerings, as well as current industry trends.

Peter DeYoung, CEO, Piramal Pharma Solutions, talks about recent company achievements and key offerings, as well as current industry trends.


Efficiency, speed-to-market, and access to unique expertise are among the key benefits of partnering with a contract development and manufacturing organization (CDMO) offering integrated, end-to-end services. Applying a fully integrated approach to drug discovery, development, manufacturing, packaging, and more, all with a single project manager as the primary point of contact and a single plan across multiple scientific disciplines, provides pharmaceutical and biotech innovators with tangible benefits. PPS has a superior record of delivering successful product launches with the seamless transfer of technology, documentation, and materials across global sites. Regulatory know-how and deep experience across a spectrum of projects and categories further solidify the company’s standing as an elite integrated CDMO.


Published: May 13th 2024 | Updated:

Published: July 30th 2021 | Updated:

Published: July 30th 2021 | Updated: